• CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to "Sell" Rating

    المصدر: Buzz FX / 07 نوفمبر 2024 01:32:16   America/Chicago


    CRISPR Therapeutics (NASDAQ:CRSP) Upgraded by StockNews.com to "Sell" Rating Written by MarketBeat November 7, 2024 Share Link copied to clipboard. CRISPR Therapeutics ( NASDAQ:CRSP - Get Free Report ) was upgraded by research analysts at S
    Read more...
شارك على،